title: Stratification of medulloblastoma on the basis of histopathological grading.
abstract: Medulloblastoma (WHO grade IV) is an embryonal tumour of the cerebellum and the most common malignant central nervous system tumour in children. Despite significant advances in treatment, 5-year survival rates are still less than 70%, suggesting the presence of subgroups with different response to radio/chemotherapy. In the present study, we re-evaluated a series of 347 medulloblastomas from the SIOP II clinical trial of the International Society of Paediatric Oncology to identify features predictive of clinical outcome. Relapse free survival for medulloblastomas with severe anaplasia [5-year rate: S(60)=49.5%], was significantly shorter than for tumours with moderate or mild anaplasia S(60)=65.4%; P=0.001). The difference between both groups was even larger when the presence or absence of extensive apoptosis was included (46.5 vs. 66.7%; P=0.0216). Other histological features including nodularity, necrosis, vascular proliferation and the presence of beta-catenin mutations (7% of cases) were not predictive for relapse free survival. These findings indicate that degree of anaplasia is the most significant histologic feature predictive of the survival of medulloblastoma patients.
authors: Department of Experimental Medicine and Pathology, University of Rome La Sapienza, 00151, Rome, Italy.
authors: Felice
authors: F
authors: Giangaspero
authors: Stefan
authors: S
authors: Wellek
authors: Jun
authors: J
authors: Masuoka
authors: Marco
authors: M
authors: Gessi
authors: Paul
authors: P
authors: Kleihues
authors: Hiroko
authors: H
authors: Ohgaki